Rodrigo Erlich
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
-
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Management of metastatic bone disease
- Pediatric Hepatobiliary Diseases and Treatments
Papers in
-
- Lung Cancer Diagnosis and Treatment 2
- Gallbladder and Bile Duct Disorders 2
- Oncology 6
- Lung Cancer Research Studies 3
- Co-authors
- Matthew J. Olnes (3 shared papers)Alexander S. Mark (1 shared paper)Andres Μ. Salazar (1 shared paper)Ronald B. Herberman (1 shared paper)Nina Bhardwaj (1 shared paper)David Schiff (1 shared paper)Marwan Fakih (1 shared paper)Theodore F. Logan (1 shared paper)
- Journals
- Cancer Investigation (3 papers)Journal of Clinical Oncology (2 papers)Annals of Oncology (1 paper)Advances in experimental medicine and biology (1 paper)Oncology (1 paper)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
Rodrigo Erlich
17 papers receiving 478 citations
Peers
Comparison fields: 5 of 55
- Oncology 145
- Surgery 212
- Immunology 100
- Pulmonary and Respiratory Medicine 110
- Genetics 28
Countries citing papers authored by Rodrigo Erlich
This map shows the geographic impact of Rodrigo Erlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Erlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Erlich more than expected).
Fields of papers citing papers by Rodrigo Erlich
This network shows the impact of papers produced by Rodrigo Erlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Erlich. The network helps show where Rodrigo Erlich may publish in the future.
Co-authors
The 25 scholars most cited alongside Rodrigo Erlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 207 | |
| 2 | 2014 | 101 | |
| 3 | 2001 | 60 | |
| 4 | 2002 | 31 | |
| 5 | 2001 | 14 | |
| 6 | 2004 | 14 | |
| 7 | 1996 | 13 | |
| 8 | 2011 | 11 | |
| 9 | 2010 | 7 | |
| 10 | 2002 | 6 | |
| 11 | 1991 | 6 | |
| 12 | A somatostatin analogue (SMS 201-995) alters the toxicity of 5-fluorouracil in Swiss mice. | 1993 | 5 |
| 13 | 2010 | 4 | |
| 14 | A rare case of anti-Hu paraneoplastic neurologic syndrome in association with cervical cancer. | 2008 | 4 |
| 15 | 2001 | 2 | |
| 16 | 2018 | 1 | |
| 17 | 2003 | 1 | |
| 18 | 2020 | 0 |
About Rodrigo Erlich
Rodrigo Erlich is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Genetics and Surgery, having authored 18 papers that have together received 487 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Neuroendocrine Tumor Research Advances (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Autoimmune Neurological Disorders and Treatments (2 papers), Gallbladder and Bile Duct Disorders (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (145 citations), Surgery (212 citations), Immunology (100 citations), Pulmonary and Respiratory Medicine (110 citations) and Genetics (28 citations). Rodrigo Erlich has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Matthew J. Olnes, Alexander S. Mark, Andres Μ. Salazar, Ronald B. Herberman, Nina Bhardwaj, David Schiff, Marwan Fakih, Theodore F. Logan, Mark D. Duncan and Theresa L. Nicol. Their work appears in journals such as Cancer Investigation, Journal of Clinical Oncology, Annals of Oncology, Advances in experimental medicine and biology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.